The AMCHAM Medical Devices Committee met under the Chairmanship of Mr. Prabal Chakraborty on 21st April 2017 in New Delhi to discuss the agenda to be taken up by the committee in the year 2017-18. The committee also reviewed the work undertaken by the committee during the last year — successes and misses. It was discussed and decided that the internal outreach to neighboring countries should continue. The committee also felt that it is important to keep interacting with U.S. Embassy officials and raise concerns of the medical devices industry both during visits of USG officials to India and by company representatives in Washington D.C. when any Indian government official is travelling to the U.S..

The other point of discussion including approaching state governments through any of the consulting firms and trying to get an interaction with the State Health Department through them. The committee members also suggested that the activity can be clubbed with organizing a half day training program for the regulators if the visit gets finalized.

Other members present during the meeting included representatives from Abbott, India Medtronic, GE, CR Bard, Boston Scientific, BD, Johnson & Johnson and Edwards Life Sciences. Mr. Gaurav Mendiratta was present from the AMCHAM Secretariat during the meeting.